HALLMARKS OF CANCER
8 HALLMARKS
• Self sufficiency in growth signals
• Insensitivity to growth inhibitory signals
• Altered cellular metabolism
• Evasion of apoptosis
• Limitless replicative potential( immortality)
• Sustained angiogenesis
• Ability to invade and metastasize
• Ability to evade host immune response
EVASION OF APOPTOSIS
EVASION OF APOPTOSIS
• Intrinsic pathway more frequently affected
• Loss of p53- prevent upregulation of PUMA(p53 induces apoptosis by
transcriptional activation of BAX and PUMA)
• Overexpression of BCL2- t(14;18)(q32;q21)
• Most haematopoietic and solidtumours expresses BCL2
• BCL2 family tumours resistant to chemo and radiotherapy
• Extrinsic pathway- decreased levels of CD95 and increased levels of
FLIP
LIMITLESS REPLICATIVE POTENTIAL
EVASION OF
SENESCENCE
EVASION OF
MITOTIC CRISIS
SELF
RENEWAL
EVASION OF SENESCENCE
• Not known
• Upregulation of tumour suppressor genes-p53 and INK4a/p16
RB in hypophosphorylated state
cell cycle arrest
suppression of p53-RB dependent-G1-S checkpoint is disrupted
EVASION OF MITOTIC CRISIS
SELF RENEWAL
• Tissue stem cell and germ cells – telomerase
• Self renewal – stem cell
one daughter cell remains as stem cell
• Symmetric and asymmetric division
SELF RENEWAL
ANGIOGENESIS
• 1-2 mm
• Supply nutrients and oxygen
• Newly formed vessels – stimulate the growth of adjacent tumour
cells(IGF and PDGF)
• Leaky,dilated and have haphazard connection- metastasis
• Angiogenic switch- production of angiogenic factors and loss of
angiogenic inhibitors
• Factors –tumour cells, macrophages, stromal cells
• Proteases – tumour cells and stromal cells ( bFGF from ECM)
ANGIOGENESIS
• Angiostatin and endostatin – proteolytic cleavage of plasminogen and
collagen respectively
• Balance between angiogenic and antgi angiogenic factors influenced by
1) Lack of O2- HIF α
activates transcription of proangiogenic cytokines-VEGF/Bfgf
stimulate proliferation of endothelial cell- new vessel towards
tumour
ANGIOGENESIS
• VEGF- increased expression of ligands for NOTCH signaling pathway
regular brancing and density of new vessel
2) Mutation involving tumour suppression gene
Favours angiogenesis
P53- stimulates expression of antiangiogenic – Thrombospondin
& represses expression of VEGF
ANGIOGENESIS
3) Transcription of VEGF- RAS MAP Kinase pathway
gain of function mutation – upregulation of VEGF
INVASION AND METASTASIS
INVASION OF
ECM
VASCULAR
DISSEMINATION
HOMING
COLONIZATION
INVASION OF ECM
• LOOSENING OF TUMOUR CELL – CELL INTERACTIONS
• DEGRADATION OF ECM
• ATTACHMENT TO NOVEL ECM COMPONENTS
• MIGRATION AND INVASION OF TUMOUR CELLS
INVASION OF ECM
INVASION OF ECM
INVASION OF ECM
INVASION AND METASTASIS
INVASION AND METASTASIS
ORGAN TROPISM
• Tumour cell adhesiom molecule- ligand on endothelial cell of target organ
• Chemokines
• Nonpermissive environment
FACTORS GOVERN METASTASIS:
• Even escape tissue of origin- inefficient to colonize distant organ
• Micro metastasis
• Tumour cell secrete cytokines,GF,ECM molecules- act on resident tumour cells –
makes metastatic site habitable for cancer cell
INVASION AND METASTASIS
• Carcinoma breast
PTHRP
osteoblasts
RANKL
Osteoclasts- degrade bone matrix
INVASION AND METASTASIS
Metastatic oncogenes- SNAIL and TWIST
epithelial mesenchymal transition
metastasis
EVASION OF HOST DEFENSE
• Products of mutated genes – altered protein variant
• Overexpressed or aberrantly expressed cellular protein
• Tumour antigen produced by oncogenic viruses
• Oncofetal antigen
• Altered cell surface glycolipids and glycoproteins
• Cell type specific differentiation antigen
EVASION OF HOST DEFENSE
Antitumour effects- CTLs, NK cell, Macrophages
EVASION OF HOST DEFENSE
IMMUNE SURVIELLANCE AND ESCAPE
• Selective outgrowth of antigen- negative variants
• Loss or expression of MHC molecule
• Activation of immunoregulatory pathways- downregulate
costimulatory receptor and activate inhibitory receptor CTLA-4
• Increased PD-L1 & PD-L2
• Immunosuppressive factors by cancer cells- TGF β and galeactin
• Induction of Tregs
EVASION OF HOST DEFENSE
EVASION OF HOST DEFENSE
THANK YOU

HALLMARKS OF CANCER.pptx - Eight hallmarks of cancer

  • 1.
  • 2.
    8 HALLMARKS • Selfsufficiency in growth signals • Insensitivity to growth inhibitory signals • Altered cellular metabolism • Evasion of apoptosis • Limitless replicative potential( immortality) • Sustained angiogenesis • Ability to invade and metastasize • Ability to evade host immune response
  • 3.
  • 4.
    EVASION OF APOPTOSIS •Intrinsic pathway more frequently affected • Loss of p53- prevent upregulation of PUMA(p53 induces apoptosis by transcriptional activation of BAX and PUMA) • Overexpression of BCL2- t(14;18)(q32;q21) • Most haematopoietic and solidtumours expresses BCL2 • BCL2 family tumours resistant to chemo and radiotherapy • Extrinsic pathway- decreased levels of CD95 and increased levels of FLIP
  • 5.
    LIMITLESS REPLICATIVE POTENTIAL EVASIONOF SENESCENCE EVASION OF MITOTIC CRISIS SELF RENEWAL
  • 6.
    EVASION OF SENESCENCE •Not known • Upregulation of tumour suppressor genes-p53 and INK4a/p16 RB in hypophosphorylated state cell cycle arrest suppression of p53-RB dependent-G1-S checkpoint is disrupted
  • 7.
  • 8.
    SELF RENEWAL • Tissuestem cell and germ cells – telomerase • Self renewal – stem cell one daughter cell remains as stem cell • Symmetric and asymmetric division
  • 9.
  • 10.
    ANGIOGENESIS • 1-2 mm •Supply nutrients and oxygen • Newly formed vessels – stimulate the growth of adjacent tumour cells(IGF and PDGF) • Leaky,dilated and have haphazard connection- metastasis • Angiogenic switch- production of angiogenic factors and loss of angiogenic inhibitors • Factors –tumour cells, macrophages, stromal cells • Proteases – tumour cells and stromal cells ( bFGF from ECM)
  • 11.
    ANGIOGENESIS • Angiostatin andendostatin – proteolytic cleavage of plasminogen and collagen respectively • Balance between angiogenic and antgi angiogenic factors influenced by 1) Lack of O2- HIF α activates transcription of proangiogenic cytokines-VEGF/Bfgf stimulate proliferation of endothelial cell- new vessel towards tumour
  • 12.
    ANGIOGENESIS • VEGF- increasedexpression of ligands for NOTCH signaling pathway regular brancing and density of new vessel 2) Mutation involving tumour suppression gene Favours angiogenesis P53- stimulates expression of antiangiogenic – Thrombospondin & represses expression of VEGF
  • 13.
    ANGIOGENESIS 3) Transcription ofVEGF- RAS MAP Kinase pathway gain of function mutation – upregulation of VEGF
  • 14.
    INVASION AND METASTASIS INVASIONOF ECM VASCULAR DISSEMINATION HOMING COLONIZATION
  • 15.
    INVASION OF ECM •LOOSENING OF TUMOUR CELL – CELL INTERACTIONS • DEGRADATION OF ECM • ATTACHMENT TO NOVEL ECM COMPONENTS • MIGRATION AND INVASION OF TUMOUR CELLS
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
    INVASION AND METASTASIS ORGANTROPISM • Tumour cell adhesiom molecule- ligand on endothelial cell of target organ • Chemokines • Nonpermissive environment FACTORS GOVERN METASTASIS: • Even escape tissue of origin- inefficient to colonize distant organ • Micro metastasis • Tumour cell secrete cytokines,GF,ECM molecules- act on resident tumour cells – makes metastatic site habitable for cancer cell
  • 21.
    INVASION AND METASTASIS •Carcinoma breast PTHRP osteoblasts RANKL Osteoclasts- degrade bone matrix
  • 22.
    INVASION AND METASTASIS Metastaticoncogenes- SNAIL and TWIST epithelial mesenchymal transition metastasis
  • 23.
    EVASION OF HOSTDEFENSE • Products of mutated genes – altered protein variant • Overexpressed or aberrantly expressed cellular protein • Tumour antigen produced by oncogenic viruses • Oncofetal antigen • Altered cell surface glycolipids and glycoproteins • Cell type specific differentiation antigen
  • 24.
    EVASION OF HOSTDEFENSE Antitumour effects- CTLs, NK cell, Macrophages
  • 25.
    EVASION OF HOSTDEFENSE IMMUNE SURVIELLANCE AND ESCAPE • Selective outgrowth of antigen- negative variants • Loss or expression of MHC molecule • Activation of immunoregulatory pathways- downregulate costimulatory receptor and activate inhibitory receptor CTLA-4 • Increased PD-L1 & PD-L2 • Immunosuppressive factors by cancer cells- TGF β and galeactin • Induction of Tregs
  • 26.
  • 27.
  • 28.